Journal article
Recombinant factor VIIA is used in a Jehova's Witness with liver cirrhosis to correct prothrombin time, bleeding time, and thromboelastographic parameters, enabling safe percutaneous injection of hepatocellular carcinoma
- Publication status:
- Published
Actions
Authors
- Journal:
- THROMBOSIS AND HAEMOSTASIS More from this journal
- Pages:
- 620-620
- Publication date:
- 1999-08-01
- ISSN:
-
0340-6245
- Pubs id:
-
pubs:66584
- UUID:
-
uuid:1b5f95a6-db68-4264-a639-afeebef73d43
- Local pid:
-
pubs:66584
- Source identifiers:
-
66584
- Deposit date:
-
2012-12-19
- ARK identifier:
Terms of use
- Copyright date:
- 1999
If you are the owner of this record, you can report an update to it here: Report update to this record